대한한방내과학회지 (The Journal of Internal Korean Medicine)

대한한방내과학회 (The Society of Internal Korean Medicine)
권호 표지
DOI QR코드

DOI QR Code

오령산 단독 투여에 의한 만성 경막하출혈 환자의 비수술적 회복

Non-surgical Recovery of a Chronic Subdural Hemorrhage Patient via the Exclusive Administration of Oryeong-san: A Case Report

  • 송주환 (원광대학교 한의과대학 내과학교실) ;
  • 지상호 (원광대학교 한의과대학 내과학교실) ;
  • 강선이 (원광대학교 한의과대학 내과학교실) ;
  • 이상관 (원광대학교 한의과대학 내과학교실) ;
  • 김철현 (원광대학교 한의과대학 내과학교실)
  • Juhwan Song (Dept. of Internal Medicine, College of Korean Medicine, Wonkwang University) ;
  • Sangho Ji (Dept. of Internal Medicine, College of Korean Medicine, Wonkwang University) ;
  • Sunny Kang (Dept. of Internal Medicine, College of Korean Medicine, Wonkwang University) ;
  • Sangkwan Lee (Dept. of Internal Medicine, College of Korean Medicine, Wonkwang University) ;
  • Cheol-Hyun Kim (Dept. of Internal Medicine, College of Korean Medicine, Wonkwang University)
  • 투고 : 2023.08.31
  • 심사 : 2023.10.26
  • 발행 : 2023.10.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Introduction: Chronic subdural hemorrhage (CSDH) primarily affects the elderly, and its incidence is rising due to aging trends. Although burr-hole craniostomy is a common treatment for CSDH, it often has a high recurrence rate and can sometimes result in poor outcomes. Oryeong-san, a traditional Korean medicine, is emerging as a potential remedy, with documented cases in both Korea and Japan. Case Presentation: In March 2021, a patient was diagnosed with an intracerebral hemorrhage in the left basal ganglia. A subsequent brain computed tomography in June 2022 revealed CSDH. Given the potential need for surgery if no CSDH absorption occurred, the patient was treated with Oryeong-san. Later computed tomography scans indicated that surgery was no longer necessary. Conclusions: This study evaluated the efficacy of Oryeong-san in treating CSDH. The results demonstrated complete CSDH absorption with no observed side effects, highlighting Oryeong-san as a promising and safe therapeutic option.

키워드

과제정보

This paper was supported by Wonkwang University in 2023.

참고문헌

  1. Holl DC, Volovici V, Dirven CMF, Peul WC, van Kooten F, Jellema K, et al. Pathophysiology and nonsurgical treatment of chronic subdural hematoma: from past to present to future. World neurosurgery 2018;116:402-11.e2. https://doi.org/10.1016/j.wneu.2018.05.037
  2. Solou M, Ydreos I, Gavra M, Papadopoulos EK, Banos S, Boviatsis EJ, et al. Controversies in the surgical treatment of chronic subdural hematoma: a systematic scoping review. Diagnostics 2022;12(9):2060.
  3. Fujisawa N, Oya S, Yoshida S, Tsuchiya T, Nakamura T, Indo M, et al. A prospective randomized study on the preventive effect of Japanese herbal Kampo medicine Goreisan for recurrence of chronic subdural hematoma. Neurologia medico-chirurgica 2020;61(1):12-20. https://doi.org/10.2176/nmc.oa.2020-0287
  4. Nakao J, Marushima A, Fujita K, Fujimori H, Mashiko R, Kamezaki T, et al. Conservative Treatment of Chronic Subdural Hematoma with Gorei-san. Neurologia medico-chirurgica 2023;63(1):31-6. https://doi.org/10.2176/jns-nmc.2022-0229
  5. Mitsuhashi T, Nagase M, Arai H. Efficacy of goreisan for asymptomatic bilateral and unilateral chronic subdural hematoma. Traditional & Kampo Medicine 2016;3(1):28-32. https://doi.org/10.1002/tkm2.1035
  6. Jeong YK, Kim SB, Yang JY, Moon SK, Jung WS, Kwon SW, et al. Two Case Studies of the Use of Oreong-san for a Chronic Subdural Hematoma. J Int Korean Med 2017;38(2):259-63. https://doi.org/10.22246/jikm.2017.38.2.259
  7. Cho KH, Kwon S, Jung WS, Moon SK. Herbal medicine, oreongsan for recurrent chronic subdural hematoma: a case report. Explore 2017;13(2):139-41. https://doi.org/10.1016/j.explore.2016.12.008
  8. Lee SH, Ha SK, Kim JH, Kim JH, Kwon TH, Park YK. Age-Specific Characteristics in Chronic Subdural Hematoma Patients. J Korean Neurotraumatol Soc 2011;7(2):83-7. https://doi.org/10.13004/jknts.2011.7.2.83
  9. Brennan PM, Kolias AG, Joannides AJ, Shapey J, Marcus HJ, Gregson BA, et al. The management and outcome for patients with chronic subdural hematoma: a prospective, multicenter, observational cohort study in the United Kingdom. Journal of neurosurgery 2016;127(4):732-9. https://doi.org/10.3171/2016.8.JNS16134
  10. Thompson PD, Panza G, Zaleski A, Taylor B. Statin-associated side effects. Journal of the American College of Cardiology 2016;67(20):2395-410. https://doi.org/10.1016/j.jacc.2016.02.071
  11. Mahmoudpour SH, Leusink M, van der Putten L, Terreehorst I, Asselbergs FW, De Boer A, et al. Pharmacogenetics of ACE inhibitor-induced angioedema and cough: a systematic review and meta-analysis. Pharmacogenomics 2013;14(3):249-60. https://doi.org/10.2217/pgs.12.206
  12. Bae IH, Kim GY, Jeong SH, Cho KH, Moon SK, Jung WS, et al. A Case Study of a Patient Who Discontinued Diuretics due to Hyponatremia and Was Treated with Korean Medicine for Ascites. J Int Korean Med 2022;43(6):1198-207. https://doi.org/10.22246/jikm.2022.43.6.1198
  13. Kwon S, Jin C, Cho KH. An herbal medicine prescription (Oreongsan) developed as a new alternative treatment in patients with chronic subdural hematoma: a narrative review. Integrative Medicine Research 2019;8(1):26-30. https://doi.org/10.1016/j.imr.2018.11.003
  14. Jeong S, Jin HW, Hwang JH, Bak JR, Jeon HS, Moon BS, et al. A case report of Korean medicine treatment for a post-traumatic hydrocephalus patient complaining of gait disturbance and dementia. J Int Korean Med 2023;44(1):77-85. https://doi.org/10.22246/jikm.2023.44.1.77